M. Laura Martin's Biography

M. Laura Martin, Director of ex vivo Models, Englander Institute for Precision Medicine, Weill Cornell Medicine

M. Laura Martin, Ph.D., is leading the Organoid Platform at Englander Institute for Precision Medicine. The Organoid Platform focus in the utilization of patient-derived models of cancer, studying the functional impact of genetic and epigenetic alterations in preclinical models, and investigating the potential to translate these findings to clinical relevance. She is also focusing in the expansion of the ex-vivo model program, improve the rate of successful model development, and increased applications for which ex-vivo models are used for research across campuses.